Journal
/
/
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
JoVE Journal
Pesquisa do Câncer
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Pesquisa do Câncer
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
DOI:

08:59 min

December 11, 2017

, , , , , ,

Capítulos

  • 00:05Título
  • 01:39Generation of Targeted Therapy Resistant Subclones
  • 04:03Restoring Target-therapy Inhibitor Sensitivity by Candidate R-gene Knock-down
  • 06:31Results: Drug Resistant Subclone Generation and Sensitivity Restoration
  • 08:01Conclusion

Summary

Tadução automática

This is a time- and cost-effective in vitro protocol investigating the mechanisms of acquired resistance to targeted therapeutic agents, which is a highly unmet medical need in cancer management.

Vídeos Relacionados

Read Article